Letter prompts new manufacturing concerns for Fosun

A second manufacturing scandal in as many weeks involving alleged falsification of manufacturing records drove down shares of Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) on Aug. 31. According to

Read the full 315 word article

User Sign In